IPO Profiles: Three VC-backed companies debuted in July on U.S. exchanges

IPO Profile: Talend SA

Company Details

Suresnes, France

33-14-625-0600

http://fr.talend.com/

Description: Talend SA is a provider of open source integration solutions for data-oriented companies and integration platform under Apache Spark. The company’s platform enables users to connect data and applications on-premise or in the cloud, in real time or in batch, Big Data or reference data. Its commercial products are Data Fabric, Big Data Integration, Real-Time Big Data, Data Preparation, Data Integration, Cloud Integration, Data Quality, Application Integration, Master Data Management and metadata Manager. Its free products are Data Preparation and Talend Open Studio, including Open Studio for Big Data, Open Studio for Data Integration, Open Studio for Data Quality, Open Studio for ESB and Open Studio for MDM. Its product, Talend Data Fabric, is a data platform. Talend Data Fabric combines big data, data integration, cloud, reference data management, data preparation and application integration in a single platform with a common development environment and management.

IPO Details

Exchange and Ticker: Nasdaq: TLND

Filing Range: 4.92 million shares @ $15 to $17

IPO Date: 7/29/16

Offering Price: $18

Closing price on first day: $25.50

Offering Size: $94.5 million

Shares Outstanding: 27.97 million

Underwriters: Goldman Sachs & Co, JP Morgan Securities Inc, Barclays Capital Group, Citigroup Global Markets Inc, William Blair & Co

Company Counsel: Wilson Sonsini Goodrich & Rosati

Manager Counsel: Goodwin Procter LLP

Auditor: KPMG

Market Capitalization on 7/29/16: $713.28 million

Closing price on 7/29/16: $25.50

Investment Details

Backers

• Idinvest Partners SA
• Balderton Capital
• Silver Lake Partners LP
• Iris Capital Management SAS
• Bpifrance Investissement SASU
• Galileo Partners

Financing Rounds

Date      Amount ($M)    Valuation ($M)

• 5/17/06 $3.9M   n/a
• 6/13/07 $3.5M   n/a
• 1/26/09 $12M     n/a
• 4/19/10 $8M       n/a
• 11/10/10 $34M     n/a
• 12/11/13 $40M     n/a

Total funding raised: $101 million

IPO Profile: Impinj Inc

Company Details

Seattle, Wash.

206-517-5300

www.impinj.com

Description: Impinj Inc is a provider of referral and information network (RAIN) radio frequency identification (RFID) solutions that provide item intelligence in the retail, pharmaceutical, healthcare, food and beverage, and other industries. The company’s products include reader chips, tag chips, readers, gateways and software. The company’s Indy reader chip/ system in package (SiP) family includes Indy R500, Indy R1000, Indy R2000, Indy RS500 SiP and Indy RS2000 SiP. The company’s Monza tag chips family includes Monza R6-P; Monza S6-C; Monza R6; Monza 5; Monza 4D, 4E, 4QT, and Monza X-2K, X-8K. The company’s fixed and mobile reader family includes Speedway enterprise, Reader Antennas, ATID AB700 and TSL 1128. The company’s gateway family includes xArray and xPortal. The company’s software family includes ItemSense and ItemEncode.

Competition: Alien Technology, Analog Devices, Broadcom, Motorola, Philips Semiconductors, STMicroelectronics, Texas Instruments, Vitesse Semiconductor

IPO Details

Exchange and Ticker: Nasdaq: PI

Filing Range: 4.6 million shares @ $12 to $14

IPO Date: 7/21/16

Offering Price: $14

Closing price on first day: $17.97

Offering Size: $67.2 million

Shares Outstanding: 13.6 million

Underwriters: RBC Capital Markets, Pacific Crest Securities Inc, Piper Jaffray, KeyBanc Capital Markets Inc

Co-manager: Canaccord Genuity

Company Counsel: Wilson Sonsini Goodrich & Rosati

Manager Counsel: Fenwick & West LLP

Auditor: PricewaterhouseCoopers LLP

Market Capitalization on 7/29/16: $251.09 million

Closing price on 7/29/16: $18.41

Investment Details

Backers

• Arch Venture Partners LLC
• Polaris Venture Partners
• Madrona Venture Group
• Foundry Group LLC
• Unilever Ventures Ltd
• Intel Capital Corp
• AllianceBernstein LP
• GF Private Equity Group LLC
• Samsung Venture Investment Corp
• GF Capital Management & Advisors LLC
• VentureTech Alliance Holdings LLC
• UPS Strategic Enterprise Fund

Financing Rounds

Date      Amount ($M)    Valuation ($M)

• 4/1/00 $600K    n/a
• 9/18/00 $15M     n/a
• 5/24/02 $14M     n/a
• 3/26/04 $22M     $38.24M
• 12/15/05 $26.5M n/a
• 3/5/07 $19.1M n/a
• 9/6/07 $7M       n/a
• 10/29/07 $4.2M   n/a
• 1/22/08 $14M     n/a
• 7/1/08 $10.6M n/a
• 7/13/12 $21.7M n/a

Total funding raised: $155 million

IPO Details: Audentes Therapeutics Inc

Company Details

San Francisco, Calif.

415-638-6556

www.audentestx.com

Description: Audentes Therapeutics Inc is a biotechnology company. The company focuses on developing and commercializing gene therapy products for patients suffering from diseases caused by single gene defects. Its portfolio of product candidates include AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM); AT342 for the treatment of Crigler-Najjar Syndrome (Crigler-Najjar); AT982 for the treatment of Pompe disease, and AT307 for the treatment of the CASQ2 subtype of Catecholaminergic Polymorphic Ventricular Tachycardia (CASQ2-CPVT). AT132 is an Adeno-associated virus (AAV) 8 vector containing a functional copy of the MTM1 gene. The company is engaged in developing AT342, which is an AAV8 vector, containing a functional version of the UGT1A1 gene. The AT982 uses an AAV serotype 9 capsid vector, containing a functional copy of the glucosidase alpha, acid (GAA) gene. The company’s principal operations are located in San Francisco, California.

IPO Details

Exchange and Ticker: Nasdaq: BOLD

Filing Range: 5 million shares @ $14 to $16

IPO Date: 7/20/16

Offering Price: $15

Closing price on first day: $15.13

Offering Size: $75 million

Shares Outstanding: 21 million

Underwriters: Bank of America Merrill Lynch, Cowen, Piper Jaffray

Co-manager: Wedbush Securities

Company Counsel: Fenwick & West LLP

Manager Counsel: Cooley LLP

Auditor: KPMG

Market Capitalization on 7/29/16: $309.42 million

Closing price on 7/29/16: $14.72

Investment Details

Backers

• Versant Venture Management LLC
• OrbiMed Advisors LLC
• Sofinnova Ventures Inc
• 5AM Ventures LLC
• Deerfield Management Company LP
• Venrock
• Rock Springs Capital Management LP
• Foresite Capital Management LLC
• Rowe Price Threshold Partnerships
• RA Capital Management LLC

Financing Rounds

Date      Amount ($M)    Valuation ($M)

• 7/18/13 $30M     n/a
• 12/20/13 $12M     n/a
• 11/21/14 $42.5M n/a
• 11/30/14 n/a         n/a
• 10/19/15 $65M     n/a

Total funding raised: $150 million

Source: Thomson Reuters data.

Photo of traders working on the floor of the NYSE courtesy of Reuters/Lucas Jackson